GeneDx Holdings Corp. (WGS)
NMS – Real vaqt narxi. Valyuta: USD
82.05
+0.31 (0.38%)
Bozor ochiq: Aug 12, 2026, 11:50 AM EDT
80.11
-1.63 (-1.99%)
Oldingi bozordan keyin: Aug 11, 2026, 7:58 PM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
82.05
+0.31 (0.38%)
Bozor ochiq: Aug 12, 2026, 11:50 AM EDT
80.11
-1.63 (-1.99%)
Oldingi bozordan keyin: Aug 11, 2026, 7:58 PM EDT
GeneDx Holdings Corp., genomika sohasidagi kompaniya, genetik testlash xizmatlarini taqdim etadi. Kompaniya asosan bolalar va kam uchraydigan kasalliklarni tashxislashni, to'liq ekzom va genom sekanslashga, shuningdek ma'lumotlar va axborot xizmatlariga qaratilgan holda taklif etadi. Shuningdek, u kam uchraydigan kasalliklar, irsiy xavf va saratonni tekshirish uchun keyingi avlod sekanslashni tahlil qilish, talqin qilish va klinik hisobot berish uchun sun'iy intellektga asoslangan platformani ishlab chiqadi. GeneDx Holdings Corp. 2000 yilda tashkil etilgan va shtab-kvartirasi Stamford, Konnektikutda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Bryan M. Dechairo Ph.D. | Chief Technology & Innovation Officer |
| Mr. Kevin Feeley CPA | Chief Financial Officer |
| Mr. Mark A. Gardner M.B.A. | President |
| Ms. Heidi C. Chen J.D. | Chief Legal Officer |
| Ms. Jami Biliboaca | Chief People Officer |
| Ms. Katherine A. Stueland | CEO & Director |
| Ms. Linda Genen M.D., M.P.H. | Chief Medical Officer |
| Ms. Lisa Gurry | Chief Business Officer |
| Ms. Melanie Duquette | Chief Growth Officer |
| Ms. Sabrina V. Dunbar | Director of Investor Relations & Communications |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-08-03 | 10-Q | wgs-20260630.htm |
| 2026-06-23 | 8-K | wgs-20260618.htm |
| 2026-06-16 | 8-K | wgs-20260615.htm |
| 2026-05-04 | 8-K | wgs-20260504.htm |
| 2026-05-04 | 10-Q | wgs-20260331.htm |
| 2026-04-30 | DEF 14A | wgs-20260430.htm |
| 2026-03-02 | 8-K | wgs-20260227.htm |
| 2026-02-23 | S-8 | s-82026evergreen.htm |
| 2026-02-23 | 8-K | wgs-20260223.htm |
| 2026-01-12 | 8-K | wgs-20260112.htm |